Surveillance for adverse events following immunization with DTaP-containing combination vaccines in Linping, China, 2019-2022
- PMID: 38596516
- PMCID: PMC11002100
- DOI: 10.3389/fpubh.2024.1278513
Surveillance for adverse events following immunization with DTaP-containing combination vaccines in Linping, China, 2019-2022
Abstract
Background: The DTaP-Hib and DTaP-IPV/Hib combination vaccine can be used as a substitute for the diphtheria, tetanus, and acellular pertussis combined vaccine (DTaP). We aimed to evaluate the safety of multi-component vaccines containing DTaP by analyzing the reporting rates and characteristics of adverse events following immunization (AEFIs) in Linping District during the years 2019 to 2022.
Methods: We obtained data of AEFI and vaccination from the National AEFI Surveillance System of China and Zhejiang Municipal Immunization Information Management System, respectively, during 2019-2022 for a descriptive, epidemiological analysis.
Results: The total number of AEFI reported following vaccinations with DTaP-containing combination vaccines was 802 in Linping District from 2019 to 2022. The overall reporting rates of AEFIs following DTaP, DTaP-Hib, and DTaP-IPV/Hib vaccinations were 445.72 (537 cases), 536.29 (45 cases), and 306.13 (220 cases) per 100,000 doses in Linping District from 2019 to 2022, respectively. Only one case of a serious AEFI following DTaP vaccination, with a reporting rate of 0.83 per 100,000 doses. The composition ratio of vaccine product-related reactions for DTaP, DTaP-Hib, and DTaP-IPV/Hib were 99.81, 97.78, and 100.00%, respectively. The composition ratio of coincidental events for DTaP and DTaP-Hib were 0.19 and 2.22%, respectively. The reporting rates of total AEFIs for DTaP-IPV/Hib were lower than for DTaP. The reporting rate of local induration for DTaP-Hib was lower than for DTaP, and the reporting rates of local redness & swelling and local induration for DTaP-IPV/Hib were both lower than for DTaP. DTaP-IPV/Hib had a higher proportion of AEFIs in first quarter compared to DTaP. The reporting rate after the second dose of DTaP-Hib was higher than that of DTaP, and the reporting rates of AEFIs after the first dose and third dose of DTaP-IPV/Hib were lower than DTaP.
Conclusion: The reported AEFIs to multi-component vaccines containing DTaP components during 2019-2022 in Linping District were mainly mild vaccine reactions. DTaP-containing combination vaccines demonstrated a good safety profile.
Keywords: AEFI; DTaP; DTaP-Hib; DTaP-IPV/Hib; reporting rate.
Copyright © 2024 Chen, Zhang, Ye, Zhu, Shen, Zhu, Yang, Liu and Xu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Adverse events following immunization of co- and separate administration of DTaP-IPV/Hib vaccines: A real-world comparative study.Hum Vaccin Immunother. 2024 Dec 31;20(1):2372884. doi: 10.1080/21645515.2024.2372884. Epub 2024 Jul 3. Hum Vaccin Immunother. 2024. PMID: 38957938 Free PMC article.
-
Safety of pentavalent DTaP-IPV/Hib combination vaccine in post-marketing surveillance in Guangzhou, China, from 2011 to 2017.Int J Infect Dis. 2020 Oct;99:149-155. doi: 10.1016/j.ijid.2020.07.019. Epub 2020 Aug 12. Int J Infect Dis. 2020. PMID: 32795602
-
[Evaluation of the safety of diphtheria, tetanus and acellular pertussis containing combination vaccines in Chengdu, 2015-2019].Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Sep 6;54(9):958-962. doi: 10.3760/cma.j.cn112150-20200417-00593. Zhonghua Yu Fang Yi Xue Za Zhi. 2020. PMID: 32907285 Chinese.
-
New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).Ann Pharmacother. 2010 Mar;44(3):515-23. doi: 10.1345/aph.1M468. Ann Pharmacother. 2010. PMID: 20197476 Review.
-
Immunogenicity and Safety of Childhood Combination Vaccines: A Systematic Review and Meta-Analysis.Vaccines (Basel). 2022 Mar 18;10(3):472. doi: 10.3390/vaccines10030472. Vaccines (Basel). 2022. PMID: 35335107 Free PMC article. Review.
Cited by
-
Real-World Effectiveness of 3 Types of Acellular Pertussis Vaccines Among Children Aged 3 Months-16 Years in Lu'an, China: A Matched Case-Control Study.Open Forum Infect Dis. 2025 Feb 10;12(2):ofaf082. doi: 10.1093/ofid/ofaf082. eCollection 2025 Feb. Open Forum Infect Dis. 2025. PMID: 39968308 Free PMC article.
-
An Evaluation of the Safety, Immunogenicity, and Protective Efficacy of a Combined Diphtheria-Tetanus-Acellular Pertussis, Haemophilus influenzae Type b, and ACYW135 Meningococcal Conjugate Vaccine in Murine and Rat Models.Vaccines (Basel). 2025 Jul 3;13(7):724. doi: 10.3390/vaccines13070724. Vaccines (Basel). 2025. PMID: 40733701 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical